ValiRx PLC
31 December 2007
ValiRx plc
(the 'Company')
Total Voting Rights
For the purposes of the transitional provisions of the Financial Services
Authority's Disclosure and Transparency Rules, the total number of ordinary
shares of 6p each in the capital of the Company in issue as at the date of this
notice is 31,613,097 with each share carrying the right to one vote.
There are no shares held in treasury.
Therefore, the total number of voting rights in the Company is 31,613,097.
The above figure may be used by shareholders in the Company as the denominator
for the calculations by which they will determine if they are required to notify
their interest in, or a change to their interest in, the share capital of the
Company under the Disclosure and Transparency Rules.
For more information please contact:
ValiRx plc WH Ireland GTH Communications
Dr Satu Vainikka David Youngman Toby Hall / Jade Mamarbachi
+44 (0) 207 408 5400 +44 (0) 161 832 2174 +44 (0) 20 7153 8035
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.